These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5970684)

  • 41. Anti-arrhythmic ancd local anaesthetic activity of some beta-receptor blocking compounds.
    Hermansen K
    Br J Pharmacol; 1968 Sep; 34(1):200P. PubMed ID: 4300140
    [No Abstract]   [Full Text] [Related]  

  • 42. [Beta-adrenolytic effect as well as influence of INPEA and MJ 1999 on refractory period and contractility of the guinea pig atrium].
    Wagner J; Schümann HJ
    Experientia; 1970; 26(2):163-4. PubMed ID: 4391796
    [No Abstract]   [Full Text] [Related]  

  • 43. [Studies on the mechanism of action of INPEA, iproveratril and oxyfedrin].
    Bosse JA; Schaum E
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):221-2. PubMed ID: 4390696
    [No Abstract]   [Full Text] [Related]  

  • 44. Myocardial and haemodynamic effects of the beta-adrenoceptor blocking drug alprenolol (H56/28) in anaesthetized cats.
    Parratt JR; Wadsworth RM
    Br J Pharmacol; 1969 Oct; 37(2):357-66. PubMed ID: 4390668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
    Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
    Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
    [No Abstract]   [Full Text] [Related]  

  • 46. [Selective beta-blocking action of practolol (ICI 50.172)].
    Novelli GP; Pagni E; Cortesini C; Pagliai P; Francini R
    Minerva Anestesiol; 1969 Dec; 35(12):1286-94. PubMed ID: 4394406
    [No Abstract]   [Full Text] [Related]  

  • 47. Beta-adrenergic blocking agents. I. Pronethalol and related N-alkyl and N-aralkyl derivatives of 2-amino-1-(2-naphythyl)ethanol.
    Howe R; Crowther AF; Stephenson JS; Rao BS; Smith LH
    J Med Chem; 1968 Sep; 11(5):1000-8. PubMed ID: 4386937
    [No Abstract]   [Full Text] [Related]  

  • 48. [Mechanism of the protective effect of dalargin on development of ischemic heart arrhythmias].
    Mikhaĭlova SD; Storozhakov GI; Bebiakova NA; Semushkina TM
    Biull Eksp Biol Med; 1996 Aug; 122(8):176-8. PubMed ID: 9081471
    [No Abstract]   [Full Text] [Related]  

  • 49. Analysis of the mechanism of adrenergic actions on ventricular vulnerability.
    Papp JG; Szekeres L
    Eur J Pharmacol; 1968 Apr; 3(1):15-26. PubMed ID: 5654666
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacology of M & B 17803A in man and dog.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1971 Oct; 43(2):468P-469P. PubMed ID: 4400577
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacological properties of 1-(4'-nitropheynl)-2-isopropylamino-ethanol (INPEA) a new beta-adrenergic receptor antagonist. 3. Direct effects on heart rate, oxygen consumption and rectal temperature and effects on the cardiac and metabolic responses to isoproterenol, adrenaline and noradrenaline in the urethan anesthetized rat.
    Murmann W; Rumore G; Gamba A
    Boll Chim Farm; 1966 Jul; 105(7):512-35. PubMed ID: 6003408
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of immediate haemodynamic effects of three beta-adrenergic blocking agents.
    Rivier JL; Nissiotis E; Jaeger M
    Postgrad Med J; 1970 Nov; ():Suppl:44-9. PubMed ID: 4395457
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of adrenergic blocking agents on lipid mobilization from canine subcutaneous adipose tissue after sympathetic nerve stimulation.
    Fredholm B; Rosell S
    J Pharmacol Exp Ther; 1968 Jan; 159(1):1-7. PubMed ID: 4384515
    [No Abstract]   [Full Text] [Related]  

  • 54. Increased plasma renin activity induced in rats by physostigmine and effects of alpha- and beta-receptors blocking drugs thereon.
    Alexandre JM; Menard J; Chevillard C; Schmitt H
    Eur J Pharmacol; 1970 Sep; 12(1):127-31. PubMed ID: 4394344
    [No Abstract]   [Full Text] [Related]  

  • 55. Cardiovascular effects of equi-antiarrhythmic doses of alprenolol (a beta-adrenergic receptor antagonist) diphenylhydantoin and procainamide.
    Proctor JD; Allen FJ; Wasserman AJ
    Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):354-67. PubMed ID: 4396926
    [No Abstract]   [Full Text] [Related]  

  • 56. Haemodynamic effects of intravenous oxoprenolol.
    Bensaid J; Scebat L; Lenegre J
    Postgrad Med J; 1970 Nov; ():Suppl:49-56. PubMed ID: 4395458
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effects of ICI 50,172 on cardio-respiratory parameters in dogs].
    Tavares P; Viana AR; Ximenes-Neto M; Martinelli JG
    Rev Bras Anestesiol; 1971; 21(4):596-601. PubMed ID: 4401689
    [No Abstract]   [Full Text] [Related]  

  • 58. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of beta-adrenoreceptor blockade and nitroglycerin on myocardial oxygenation.
    Winbury MM; Weiss HR; Howe BB
    Eur J Pharmacol; 1971; 16(3):271-7. PubMed ID: 4399875
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.